CIHR Funding Opportunity — Data Analysis using Existing Databases and Cohorts

CIHR has announced an Operating Grant competition, Data Analysis Using Existing Databases and Cohorts sponsored by the CIHR Healthy Cities Research Initiative. “This HCRI funding opportunity will support research that leverages existing data to improve the health, wellness and health equity of urban populations. CIHR and other funding agencies have invested heavily in the establishment of cohorts, databases, and data platforms. As a result, many high-quality data sets exist that contain a wealth of information and have the potential to answer research questions that go beyond those for which the data were originally collected or for which the data has been used to date. Examples of such resources include but are not limited to data available through Statistics Canada’s Research Data Centres, the Canadian Institute for Health Information, the Canadian Partnership for Tomorrow Project (CanPath) and the Canadian Longitudinal Study on Aging (CLSA), as well as administrative datasets, surveys, large data linkage projects and cohort catalogues that bring together datasets from multiple sources such as the Canadian Urban Environmental Health Research Consortium (CANUE).“* *Please note that CANUE data has been linked to all CanPath participants and is held by the regional cohorts, and other linkages already exist and/or are possible.  Funds Available “The total amount available for this funding opportunity is $700,000, enough to fund approximately seven (7) one (1) year grants of up to $100,000 each. This amount may increase if additional funding partners participate.” Deadline: November 8, 2023 Anticipated Notice of Decision: February 28, 2024 Funding Start Date: March 1, 2024 Additional Details: https://www.researchnet-recherchenet.ca/rnr16/vwOpprtntyDtls.do?all=1&masterList=true&next=1&org=CIHR&prog=3891&resultCount=25&sort=program&type=EXACT&view=currentOpps&language=E

CanPath Webinar: COVID-19 Findings

CanPath Webinar: Real-World Insights on COVID-19 Vaccine Effectiveness and Infection Risk Factors from CanPath’s SUPPORT-Canada Study May 30th, 12-1pmEST/1-2pmAST Register: https://canpath.ca/2023/04/hybrid-event-covid-19-vaccine-effectiveness-support-canada-study/ Join us for an in-depth analysis of COVID-19 vaccine effectiveness based on real-world data from the SUrveying Prospective Population cOhorts for COVID-19 pRevalence and ouTcomes in Canada’ (SUPPORT-Canada) study. Led by Victoria Kirsh, this webinar will provide an overview of the study population, data collection, and statistical models used to analyze risk factors for infection and vaccine effectiveness against the Omicron variant. You’ll learn about the importance of time since last vaccination as the most critical determinant of protection against infection, more so than the number of vaccinations. Dr. Kirsh will also discuss the benefits and drawbacks of different vaccines and booster shots, including the latest findings on bivalent vs. monovalent boosters. Don’t miss this opportunity to stay up-to-date on the latest research and insights into COVID-19 vaccine effectiveness. About the Presenter: Dr. Victoria Kirsh is the Scientific Associate at the Ontario Health Study, one of CanPath’s regional cohorts. Dr. Kirsh completed a Ph.D. in Epidemiology from Yale University, an M.Sc. in Epidemiology from the University of Toronto and a B.Sc. in Microbiology and Immunology from McGill University. She completed a fellowship at the U.S. National Cancer Institute, Division of Cancer Epidemiology and Genetics. She worked as an Assistant Professor at the Dalla Lana School of Public Health, University of Toronto, and as a Scientist at Cancer Care Ontario before joining the Ontario Health Study.

Join us in Halifax — CCRA Call for Abstracts

The Canadian Cancer Research Conference provides an excellent opportunity to present research to the cancer community. Abstract submissions from the entire spectrum of research topics are welcome. Abstract submission for the 2023 Canadian Cancer Research Conference is now open.  Abstract submission deadline: Friday, June 9, 2023 at 11:59 PM (midnight) EDT Abstract submissions from the entire spectrum of cancer research topics are welcome. The online abstract submission process is bilingual. Abstract submissions will be accepted in both English and French. Abstracts will appear in the language of submission, and posters may be prepared and presented orally in the presenter’s language of choice. Please note all lightning and oral presenters must present in person at the 2023 CCRC in Halifax. Additional details: https://www.ccra-acrc.ca/conference/abstracts/  

Keynote Lecture

Atlantic PATH Scientific Director, Dr. Robin Urquhart was the key note speaker at the 8th annual Charbonneau Research Symposium. The Arnie Charbonneau Cancer Institute is based at the University of Calgary and brings together scientists and physicians to integrate research and care across disciplines – from understanding and preventing cancer, to transforming its detection and treatment, to improving life with and after cancer. The Arnie Charbonneau Cancer Institute Annual Research Symposium is a one day series of short lectures from principal investigators from across our different research streams. Dr. Urquhart presented on “Accelerating Change in the Cancer System: Dispatches from the Frontlines of Research and Practice.”

Webinar: Using the Canadian Parternship for Tomorrow’s Health to Identify the Earliest Determinants of Disease Evolution and Aging

Join us on Thursday, March 30th at 9am EST (10amAST) to learn about using the Canadian Partnership for Tomorrow’s Health to identify the earliest determinants of disease evolution and aging. Registration details: https://ihccglobal.org/ihcc-educational-webinar-series/. Properly consented population cohorts are incredibly valuable for studying the factors associated with aging and disease before the first diseases are diagnosed. In the Canadian Partnership for Tomorrows Health (CanPath) we have recruited over 350,000 participants who have consented to provide biologics, physical measures and health information longitudinally, while also consenting to follow-ups through health records over the next 30-50 years. Our studies genomic and molecular phenotyping studies have identified a number of critical factors associated with the development of cancers pre-diagnosis. Utilizing single-cell approaches we have identified alternative factors associated with healthy blood aging. Together, CanPath demonstrates the power of population cohorts to support early disease and prevention studies that are impacting health policy. Dr. Philip Awadalla is the National Scientific Director of the Canadian Partnership for Tomorrows Health (CanPath) and is the Executive Director of the Ontario Health Study (OHS). He is a Professor the Department of Molecular Genetics, and School of Public Health, at the University of Toronto. He is the Director of Computational Biology at the Ontario Institute of Cancer Research where he leads a research program studying the genomic and environmental determinants of early cancer evolution, aging, and studies fundamental processes shaping genomic variation. He is on the Steering Committee of International Hundred Thousand + Cohort Consortium.

The Ontario Public Health Convention (TOPHC)

Dr. Ellen Sweeney (Research Director, Atlantic PATH) and Dr. Victoria Kirsh (Scientific Associate, Ontario Health Study) were pleased to attend the Ontario Public Health Convention (TOPHC) on behalf of CanPath. Dr. Sweeney presented on CanPath’s resources for research on chronic disease and cancer and Dr. Kirsh presented on risk factors for COVID-19 infection among CanPath participants. TOPHC is created by and for public health professionals and delivers workshops, presentations, and keynote presentations focused on the unique experiences, challenges and opportunities in public health today. TOPHC events offer a chance for public health professionals to learn from each other, get inspired, provoke thought and move forward to make a difference in their careers and communities (https://www.tophc.ca/).